Mysthenogravis Foundation of America - Is This a Refractory Disease?

In the simactime trial, really kind of mild to moderate generalized m g. And the patients tended to be l but on the younger side. The mediun age was 33 in the pretizon lone group and 32 in the simactim and predizone group. So i sometimes have trouble making a fi mectime recommendation for patients who don't fit squarely into this cohort. I want to ask you some one sentence scenarios, some of which i think i can predict your answer, and a few that i don't think i do know your answer.